Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice

Anupa Kudva, Erich V. Scheller, Keven M. Robinson, Chris R. Crowe, Sun Mi Choi, Samantha R. Slight, Shabaana A. Khader, Patricia J. Dubin, Richard I. Enelow, Jay K. Kolls, John F. Alcorn

Research output: Contribution to journalArticlepeer-review

252 Scopus citations


Staphylococcus aureus is a significant cause of hospital and community acquired pneumonia and causes secondary infection after influenza A. Recently, patients with hyper-IgE syndrome, who often present with S. aureus infections of the lung and skin, were found to have mutations in STAT3, required for Th17 immunity, suggesting a potential critical role for Th17 cells in S. aureus pneumonia. Indeed, IL-17R-/- and IL-22-/- mice displayed impaired bacterial clearance of S. aureus compared with that of wild-type mice. Mice challenged with influenza A PR/8/34 H1N1 and subsequently with S. aureus had increased inflammation and decreased clearance of both virus and bacteria. Coinfection resulted in greater type I and II IFN production in the lung compared with that with virus infection alone. Importantly, influenza A coinfection resulted in substantially decreased IL-17, IL-22, and IL-23 production after S. aureus infection. The decrease in S. aureus-induced IL-17, IL-22, and IL-23 was independent of type II IFN but required type I IFN production in influenza A-infected mice. Furthermore, overexpression of IL-23 in influenza A, S. aureus-coinfected mice rescued the induction of IL-17 and IL-22 and markedly improved bacterial clearance. These data indicate a novel mechanism by which influenza A-induced type I IFNs inhibit Th17 immunity and increase susceptibility to secondary bacterial pneumonia.

Original languageEnglish
Pages (from-to)1666-1674
Number of pages9
JournalJournal of Immunology
Issue number3
StatePublished - Feb 1 2011


Dive into the research topics of 'Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice'. Together they form a unique fingerprint.

Cite this